The Chicago Entrepreneur

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

Editorial Team

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Data Update 1 for 2025: The Draw (and Danger) of Data
Next post Comcast and Harris Blitzer to build new NBA, NHL stadium in South Philadelphia